Literature DB >> 9736236

Sarcoidosis in children. Epidemiology in Danes, clinical features, diagnosis, treatment and prognosis.

N Milman1, A L Hoffmann, K E Byg.   

Abstract

This paper reviews current knowledge of childhood sarcoidosis with regard to the epidemiology in Danes, clinical presentation, diagnostic procedures, treatment and prognosis. Sarcoidosis is a granulomatous disease of unknown aetiology, with multiorgan involvement. The diagnosis is confirmed by the demonstration of epitheloid cell granulomas in tissue biopsy specimens. During the period 1980-92, three cases of childhood sarcoidosis were recorded in Copenhagen County, which has a total population of 610,000. The approximate incidence of clinically recognized sarcoidosis in Danish children younger than 15 y of age was 0.22-0.27/100,000 children per year, corresponding to approximately three new cases in Denmark each year. The true incidence is unknown, since the disease is often asymptomatic and resolves without a clinical diagnosis being made. In children younger than 5 y of age, the disease is characterized by involvement of skin, eyes and joints, whereas in older children involvement of lungs, lymph nodes and eyes predominate. The mainstay of treatment consists of oral corticosteroids. The risk/benefit ratio of using long-term corticosteroids needs to be evaluated in each individual patient. Some patients may benefit from additional therapy with methotrexate. The long-term prognosis is not well established, but it seems to be poorer in children younger than 5 y. Older children appear to have as favourable a prognosis as young adults.

Entities:  

Mesh:

Year:  1998        PMID: 9736236     DOI: 10.1080/080352598750013662

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  15 in total

1.  Juvenile sarcoidosis presenting as Crohn's disease.

Authors:  Jürgen Brunner; Consolato Sergi; Thomas Müller; Ingmar Gassner; Friederike Prüfer; Lothar Bernd Zimmerhackl
Journal:  Eur J Pediatr       Date:  2006-03-18       Impact factor: 3.183

2.  Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil.

Authors:  Asha Moudgil; Ronald M Przygodzki; Kanwal K Kher
Journal:  Pediatr Nephrol       Date:  2005-12-17       Impact factor: 3.714

Review 3.  Distinguishing Blau Syndrome from Systemic Sarcoidosis.

Authors:  Katherine P Kaufman; Mara L Becker
Journal:  Curr Allergy Asthma Rep       Date:  2021-02-09       Impact factor: 4.806

Review 4.  The puzzling clinical spectrum and course of juvenile sarcoidosis.

Authors:  Andrew Fretzayas; Maria Moustaki; Olga Vougiouka
Journal:  World J Pediatr       Date:  2011-05-15       Impact factor: 2.764

5.  Mizoribine for renal sarcoidosis: effective steroid tapering and prevention of recurrence.

Authors:  Shuichi Ito; Tomonori Harada; Tomoko Nakamura; Tomoyuki Imagawa; Kiyotaka Nagahama; Takeshi Sasaki; Shuichiro Fujinaga; Yukoh Aihara; Shumpei Yokota
Journal:  Pediatr Nephrol       Date:  2008-09-13       Impact factor: 3.714

6.  Sarcoidosis: child vs adult.

Authors:  Halil Yanardag; Omer Nuri Pamuk; Sedat Uygun; Sabriye Demirci; Tuncer Karayel
Journal:  Indian J Pediatr       Date:  2006-02       Impact factor: 1.967

7.  Imaging of Childhood Interstitial Lung Disease.

Authors:  R Paul Guillerman
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

8.  A case of scar sarcoidosis.

Authors:  Young Chul Hong; Dong Jib Na; Sang Hoon Han; Yang Deok Lee; Yong Seon Cho; Min Soo Han
Journal:  Korean J Intern Med       Date:  2008-12       Impact factor: 2.884

9.  Isolated facial cutaneous sarcoidosis.

Authors:  Sumir Kumar; Ravinder Garg; Simmi Aggarwal; Jaskanwal Kaur
Journal:  J Nat Sci Biol Med       Date:  2012-01

10.  Elevated aminotransaminases as the first manifestation of sarcoidosis.

Authors:  Georges Nawfal; Christelle Budin; Raymonde Bouvier; Alain Lachaux
Journal:  Case Rep Med       Date:  2009-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.